Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 8,349,346 $ 17,002,715
Investments 28,216,560 42,194,296
Restricted cash 192,475 192,475
Prepaid expenses and other current assets 1,515,616 791,616
Total current assets 38,273,997 60,181,102
Restricted cash 477,425 477,425
Property and equipment, net 1,273,602 1,613,815
Operating lease right of use assets 3,486,416 3,884,252
Other assets 211,943 155,346
Total assets 43,723,383 66,311,940
Current liabilities:    
Notes payable 51,157 353,323
Accounts payable 1,505,734 2,173,963
Accrued expenses 6,418,803 5,999,252
Derivative liability 36,868 36,868
Operating lease liabilities, current 1,357,240 1,280,863
Current portion of long-term debt 7,016,096 2,795,669
Total current liabilities 16,385,898 12,639,938
Long-term debt, net of debt discount 11,319,365 15,984,426
License agreement payable, noncurrent 2,500,000 0
Other long-term liabilities 22,205 22,205
Operating lease liabilities, noncurrent 3,975,329 4,675,354
Total liabilities 34,202,797 33,321,923
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no sharesissued and outstanding at June 30, 2023 and December 31, 2022. See Note 11 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized,4,422,741 and 4,171,297 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 442 417
Additional paid-in capital 428,153,252 425,196,359
Accumulated deficit (418,609,320) (392,080,667)
Accumulated other comprehensive loss (23,788) (126,092)
Total stockholders’ equity 9,520,586 32,990,017
Total liabilities and stockholders’ equity $ 43,723,383 $ 66,311,940